Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: A single surgeon experience

Brachytherapy

Volumn 10, Issue 3, 2011, Pages 228-231

  Karlovits, Brian ^a   Trombetta, Mark G ^a,b   Verstraeten, Thierry ^a,b   Johnson, Mark ^a   Wong, Michael ^b   Karlovits, Stephen ^a,b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Brachytherapy; Choroidal; COMS; Eye; Melanoma; Ocular; Plaque

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CATARACT; CHOROID MELANOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MALE; MORTALITY; OPTIC NERVE DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RETINA DETACHMENT; RETINA MACULOPATHY; RETINOPATHY; SURGEON; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; VISUAL ACUITY; WORK EXPERIENCE;

ADULT; BRACHYTHERAPY; EQUIPMENT DESIGN; EYE NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 79955136030     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.09.003     Document Type: Article

References (23)

1. Singh A.D., Bergman L., Seregard S. Uveal melanoma: Epidemiologic aspects. Ophthalmol Clin North Am 2005, 18:75-84.
2. Finger P.T. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997, 42:215-232. [review].
3. Zimmerman L.E., McLean I.W., Foster W.D. Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation. Ophthalmology 1980, 87:557-564.
4. De Potter P., Shields C.L., Shields J.A. New treatment modalities for uveal melanoma. Curr Opin Ophthalmol 1996, 7:27-32.
5. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: III. Initial mortality findings: COMS Report No. 18. Arch Ophthalmol 2001, 119:969-982. Collaborative Ocular Melanoma Study Group.
6. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS Report No. 28. Arch Ophthalmol 2006, 124:1684-1693. Collaborative Ocular Melanoma Study Group.
7. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy: COMS report no. 19. Ophthalmology 2002, 109:2197-2206. Collaborative Ocular Melanoma Study Group.
8. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: I. Visual acuity after 3 years: COMS Report No. 16. Ophthalmology 2001, 108:348-366. Collaborative Ocular Melanoma Study Group.
9. 125I episcleral plaque brachytherapy in the treatment of choroidal melanoma: A single-institution experience in Spain. Brachytherapy 2009, 8:290-296.
10. Fontanesi J., Meyer D. Twenty-five years experience with I-125 for ocular melanoma. Brachytherapy 2008, 7:162-163.
11. COMS manual of procedures 1995, Collaborative Ocular Melanoma Study Group, National Technical Information Service, Springfield, VA, Accession No. PB91-217315.
12. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
13. Jensen A.W., Petersen I.A., Kline R.W., et al. Radiation complications and tumor control after 125 I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 2005, 63:101-108.
14. Finger P.T., Romero J.M., Rosen R.B., et al. Three-dimensional ultrasonography of choroidal melanoma: Localization of radioactive eye plaques. Arch Ophthalmol 1998, 116:305-312.
15. Hanna S.L., Lemmi M.A., Langston J.W., et al. Treatment of choroidal melanoma: MR imaging in the assessment of radioactive plaque position. Radiology 1990, 176:851-853.
16. Harbour J.W., Murray T.G., Byrne S.F., et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina 1996, 16:129-134.
17. Tabandeh H., Chaudhry N.A., Murray T.G., et al. Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma. Am J Ophthalmol 2000, 129:199-204.
18. Finger P.T., Iezzi R., Romero J.M., et al. Plaque-mounted diode-light transillumination for localization around intraocular tumors. Arch Ophthalmol 1999, 117:179-183.
19. 125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1993, 26:613-618.
20. Jones R., Gore E., Mieler W., et al. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: Dose and dose rate effects. Int J Radiat Oncol Biol Phys 2002, 52:989-995.
21. Brady L.W., Hernandez J.C. Brachytherapy of choroidal melanomas. Strahlenther Onkol 1992, 168:61-65. [editorial].
22. 125I plaque therapy for uveal melanoma-Analysis of the impact of time and dose factors on local control. Cancer 1996, 77:2356-2362.
23. Gunduz K., Shields C.L., Shields J.A., et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999, 127:579-589.